“The phase III trial of the ‘Covishield’ vaccine will begin at Sassoon hospital starting next week. It is likely to start on Monday. Some volunteers have already come forward for the trial. The candidate dose of the vaccine will be administered. between 150 and 200 volunteers, “he said.
More about Covid-19
“Starting Saturday, the hospital began enrolling volunteers for the trial. Those who are willing to volunteer for the vaccination should contact the hospital,” he said.
In phase II, the trials were conducted at Bharti Vidyapeeth Medical College and also at the city’s KEM Hospital.
IBS has partnered with the British-Swedish pharmaceutical company AstraZeneca to manufacture the Covid-19 candidate vaccine, developed by the University of Oxford.
Earlier this month, IBS had halted clinical trials of the candidate vaccine in the country.
The Comptroller General of Drugs of India (DCGI) had ordered the SII on September 11 to suspend any new recruitment in the phase II and III clinical trial of the vaccine until further orders after AstraZeneca halted trials in other countries due to to “an unexplained illness” in a study participant.
However, on September 15, the DCGI gave IBS permission to resume the clinical trial of the vaccine.
.
